| Name | Title | Contact Details |
|---|
Evofem, Inc. is a privately held biotechnology company that discovers, develops and commercializes prescription and over-the-counter products in the areas of feminine care, contraception, and the prevention of sexually transmitted infections. Evofem, Inc. is committed to delivering effective, woman-controlled, rapidly reversible forms of contraception to women globally. In February 2013, Evofem entered into a strategic alliance with Woman Care Global, a nonprofit organization whose mission is to provide access to quality, affordable, women`s healthcare products through a sustainable value chain in over 100 countries, with a particular focus on under-served markets in Africa, Asia, and Latin America. Through this alliance, Woman Care Global provides sales, marketing and global distribution support to Evofem`s products.
OXiGENE is a biopharmaceutical company developing new and improved therapeutics that have the potential to deliver significant medical benefits to patients with cancer and serious medical conditions. Our primary focus is developing first-in-class anti-vascular drugs referred to as vascular disrupting agents (VDAs). Our lead compound in clinical development is fosbretabulin. VDAs are a new and highly differentiated class of anti-vascular drug that target existing tumor vasculature, leading to extensive tumor cell death. VDAs target the tumor vasculature rather than the tumor cells and therefore have broad potential therapeutic utility in cancer. Because VDAs act differently than anti-angiogenic drugs or cytotoxic chemotherapy drugs, VDAs are potentially complementary with anti-angiogenic drugs and chemotherapeutic agents. OXiGENE has ongoing VDA drug development programs and is committed to advancing the science of VDAs and their potential as innovative therapies to address unmet medical needs.
Panbio is a Columbia, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Visual Sonics is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At Vyaire, we know that each patient has different goals—and every breath counts to achieve them. We are a company on the move, relentlessly innovating, challenging the status quo and keeping patient needs at the forefront of everything we do to enable, enhance and extend lives. Established from legacy brands with a 65-year history of pioneering breathing technology, Vyaire Medical Inc. is a global company focused exclusively on supporting breathing through every stage of life. We pledge to evolve what`s possible to ensure every breath is taken to its fullest. We accomplish this through our values: One Voice, Patient Purpose, Promises Kept and Expansive Innovation. The company`s origin began in the 1950s with the invention of the first mechanical ventilator and has since brought together well-known brands with proven track-records of pioneering and advancing respiratory diagnostics, ventilation, and anesthesia delivery and monitoring. Formed in 2016, the unified Vyaire established the world`s largest consortium of experts and industry leaders solely focused on the breathing continuum for customers and patients across the globe. Vyaire`s passionate, dedicated global workforce of 4,000 consists of experienced breathing specialists that are inspired and empowered to elevate the quality of each inhale and each exhale. Vyaire acknowledges and celebrates the individual backgrounds, perspectives, and voices of our team members to best serve the diverse needs of patients and healthcare providers. Bring your unique talents, commitment, and career aspirations to our global team of dedicated professionals. Headquartered in suburban Chicago, Vyaire is recognized, trusted and preferred by specialists throughout the respiratory community worldwide.